IRF2BP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.455400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.397000E-01
Normal-vs-Stage2
4.823200E-01
Normal-vs-Stage3
6.915000E-01
Normal-vs-Stage4
3.836600E-01
Stage1-vs-Stage2
5.667800E-02
Stage1-vs-Stage3
1.332750E-01
Stage1-vs-Stage4
5.806200E-01
Stage2-vs-Stage3
2.025600E-01
Stage2-vs-Stage4
5.763400E-01
Stage3-vs-Stage4
2.532200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.687600E-01
Normal-vs-AfricanAmerican
3.177600E-01
Normal-vs-Asian
3.510800E-01
Caucasian-vs-AfricanAmerican
2.757200E-01
Caucasian-vs-Asian
4.467800E-01
AfricanAmerican-vs-Asian
7.238400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.069400E-01
Normal-vs-Female
3.724400E-01
Male-vs-Female
3.653800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.543000E-01
Normal-vs-Age(41-60Yrs)
1.674830E-01
Normal-vs-Age(61-80Yrs)
6.014200E-01
Normal-vs-Age(81-100Yrs)
3.832200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.044400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.679800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.078200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.070200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.442200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.427400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.656800E-01
Normal-vs-Daily Drinker
6.908600E-01
Normal-vs-Weekly Drinker
7.521600E-01
Normal-vs-Occasional Drinker
4.885600E-02
Normal-vs-Social Drinker
2.947200E-01
Non Drinker-vs-Daily Drinker
8.338000E-01
Non Drinker-vs-Weekly Drinker
9.016600E-01
Non Drinker-vs-Occasional Drinker
1.004370E-02
Non Drinker-vs-Social Drinker
1.644840E-01
Daily Drinker-vs-Weekly Drinker
7.997800E-01
Daily Drinker-vs-Occasional Drinker
5.976200E-02
Daily Drinker-vs-Social Drinker
3.589800E-01
Weekly Drinker-vs-Occasional Drinker
2.612400E-02
Weekly Drinker-vs-Social Drinker
2.297400E-01
Occasional Drinker-vs-Social Drinker
4.086200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.441600E-02
Normal-vs-Grade 2
1.338570E-03
Normal-vs-Grade 3
1.177240E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.774400E-01
Grade 1-vs-Grade 3
8.494200E-01
Grade 1-vs-Grade 4
7.441600E-02
Grade 2-vs-Grade 3
6.562000E-01
Grade 2-vs-Grade 4
1.338570E-03
Grade 3-vs-Grade 4
1.177240E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.006600E-01
Normal-vs-NonDiabetic
4.092000E-01
Diabetic-vs-NonDiabetic
9.338300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.601800E-01
Normal-vs-NoPancreatitis
4.916200E-01
Pancreatitis-vs-NoPancreatitis
3.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.551800E-01
Normal-vs-N1
4.811600E-01
N0-vs-N1
5.130200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.404200E-01
Normal-vs-TP53-NonMutant
3.716000E-01
TP53-Mutant-vs-TP53-NonMutant
8.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
